TLR4 and rheumatoid arthritis: Early preclinical studies report a role for TLR4 antagonists in reversal of inflammation in RA and improvement in allodynia and hyperalgesia in nerve pain models and therefore of potential benefit for both inflammatory and nociplastic pain in RA [84].